Excluding the elevated control subject, two of the MM patients had antibody levels above the threshold defined by the control group (ie mean+2 standard deviations of the mean) including the index patient in which the original reactivity to vimentin was demonstrated (Figure 6). Here, VIM is linked to Miyoshi myopathy.